Long-term vision and ambition brings confidence
We attended LDR’s investor day on Wednesday 23rd February and returned confident in the company’s long term growth prospects with management having shared its plan to further penetrate the cervical market as well as details on minimum implant volume surgery (MIVO). For the first time, management communicated on Mobi-C sales in USD. A surgeon’s testimony highlighted the advantages of Mobi-C vs. competitor’s products as well as interest in MIVO products, which LDR is to roll-out in the US.
For more information, please contact email@example.com